Sana Biotechnology, Inc.
SANA
$3.27
-$0.09-2.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.48% | -0.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.64% | 3.27% | |||
| Operating Income | -15.64% | -3.27% | |||
| Income Before Tax | -39.55% | 55.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.55% | 55.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.55% | 55.06% | |||
| EBIT | -15.64% | -3.27% | |||
| EBITDA | -17.14% | -2.69% | |||
| EPS Basic | -31.77% | 58.87% | |||
| Normalized Basic EPS | -2.55% | 5.78% | |||
| EPS Diluted | -31.77% | 58.87% | |||
| Normalized Diluted EPS | -2.55% | 5.78% | |||
| Average Basic Shares Outstanding | 5.91% | 9.26% | |||
| Average Diluted Shares Outstanding | 5.91% | 9.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||